Qube Research & Technologies »

Horizon Therapeutics shares owned by Qube Research & Technologies

Quarter-by-quarter ownership of Horizon Therapeutics shares owned by Qube Research & Technologies from 13F filings

Historical chart of Qube Research & Technologies investment in Horizon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Horizon Therapeutics held by Qube Research & Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Horizon Therapeutics by Qube Research & Technologies

Quarter filed Position value Share count Share price at filing
2023-09-30 $84M 727k 115.69
2023-06-30 $59M 569k 102.85
2023-03-31 $73M 666k 109.14
2022-09-30 $17M 267k 61.89
2022-06-30 $51M 641k 79.76
2022-03-31 $37M 347k 105.21
2021-12-31 $28M 262k 107.76
2021-03-31 $1.7M 18k 92.05
2020-09-30 $9.2M 118k 77.68
2020-06-30 $1.3M 24k 55.59

More positions owned by Qube Research & Technologies

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Amazon Call Option (AMZN)
Visa Com Cl A Call Option (V)
Meta Platforms Cl A Call Option (META)
Adobe Systems Incorporated Call Option (ADBE)
McDonald's Corporation Call Option (MCD)
NVIDIA Corporation Call Option (NVDA)
salesforce Call Option (CRM)
Netflix Call Option (NFLX)
Johnson & Johnson Put Option (JNJ)
Cisco Systems Put Option (CSCO)
Bank of America Corporation Call Option (BAC)

View all positions for Qube Research & Technologies

Top funds holding Horizon Therapeutics

IFP Advisors
Beacon Capital Management
Huntington National Bank

View all funds holding Horizon Therapeutics